DE BERTI JACCHIA VINCE AL TRIBUNALE DI SALERNO PER GLAXOSMITHKLINE

marketude

De Berti Jacchia, con il partner David Maria Santoro, ha assistito con successo GlaxoSmithKline S.p.A. e GlaxoSmithKline Biologicals S.A. davanti al Tribunale di Salerno, in una delicata controversia in tema di responsabilità da prodotto farmaceutico.

PRATICHE ANTICONCORRENZIALI. L’AG SZPUNAR SI PRONUNCIA SULLE AZIONI DI RISARCIMENTO DEL DANNO AI SENSI DEL DIRITTO NAZIONALE PER VIOLAZIONI DEL DIRITTO ANTITRUST DEGLI STATI MEMBRI E DELL’UNIONE

marketude Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo

[x_icon type="tag"] EU and Competition, Litigation, Perspectives

RIFORMA GIUSTIZIA CIVILE: NOMINATI I GRUPPI DI LAVORO PER L’ATTUAZIONE DELLA DELEGA

marketude Riccardo Vitolo, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Stefania Merati

[x_icon type="tag"] Litigation, Perspectives

DIRETTIVE SELF-EXECUTING, DOVERE DI DISAPPLICAZIONE, GIUDICATO E SOPRAVVENIENZE NORMATIVE. IL CONSIGLIO DI STATO PONE FINE ALLA STORICA PROROGA AUTOMATICA DELLE CONCESSIONI DEMANIALI MARITTIME

marketude Administrative and Public Law, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives

[x_icon type="tag"] Administrative and Public Law, Litigation, Perspectives

NEL CASO ALTICE IL TRIBUNALE DELL’UNIONE CONFERMA UNA POLITICA GIUDIZIARIA RIGOROSA IN MATERIA DI “GUN JUMPING”

marketude EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition

[x_icon type="tag"] EU and Competition, Litigation, Perspectives

MEDICINALI PER USO UMANO SOGGETTI A PRESCRIZIONE MEDICA. LIBERA CIRCOLAZIONE DELLE MERCI E DIVIETO DI OFFRIRE, PUBBLICIZZARE O CONCEDERE OMAGGI NELLE VENDITE PER CORRISPONDENZA

marketude Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

DE BERTI JACCHIA VINCE PER GLAXOSMITHKLINE SULLA RESPONSABILITÀ DA PRODOTTI FARMACEUTICI

marketude

Sono state pubblicate in rapida successione tre decisioni che hanno definito altrettanti procedimenti giudiziari nei quali De Berti Jacchia, con il partner David Maria Santoro, ha assistito con successo GlaxoSmithKline S.p.A. ed altre società collegate dell’omonimo gruppo farmaceutico anglosassone, ritenute responsabili di danni – patrimoniali e non – legati all’impiego di propri prodotti.

DIRITTI DI PROPRIETÀ INTELLETTUALE E STANDARD PER LA CONCESSIONE DI MISURE CAUTELARI SECONDO LA DIRETTIVA 2004/48/CE. UN RINVIO PREGIUDIZIALE DEL LANDGERICHT MÜNCHEN ALLA CORTE DI GIUSTIZIA

marketude Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications

[x_icon type="tag"] EU and Competition, Intellectual Property, Litigation

VACCINI, SALUTE E DIRITTO CAMMINANO FIANCO A FIANCO

marketude Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences

[br]